09:29 AM EST - Tetra Bio-Pharma Inc. : Announced today significant results from the study of Onternabez combined with Favipiravir against ARDS (acute respiratory distress syndrome), Sepsis, and COVID-19 through PREPAiRE, an AI (Artificial Intelligence) powered platform which purposely integrates target identification, validation, lead discovery optimization, drug synthesis, and preclinical testing. Leveraging the power of AI enables more answers and greater insights, faster. Tetra Bio-Pharma Inc.
shares T.TBP are trading down $0.01 at $0.03.
